PACAP-38 induces neuronal differentiation of human SH-SY5Y neuroblastoma cells via cAMP-mediated activation of ERK and p38 MAP kinases
2008

PACAP-38 and Neuronal Differentiation in SH-SY5Y Cells

publication Evidence: high

Author Information

Author(s): Monaghan T K, MacKenzie C J, Plevin R, Lutz E M

Primary Institution: Strathclyde Institute of Pharmacy and Biomedical Sciences, Royal College Glasgow, UK

Hypothesis

PACAP-38 induces neuronal differentiation of human SH-SY5Y neuroblastoma cells via cAMP-mediated activation of ERK and p38 MAP kinases.

Conclusion

PACAP-38 promotes neuronal differentiation in SH-SY5Y cells through a cAMP-dependent mechanism involving ERK and p38 MAP kinase activation.

Supporting Evidence

  • PACAP-38 caused a concentration-dependent increase in the number of neurite-bearing cells.
  • The expression of neuronal proteins Bcl-2 and GAP-43 was up-regulated by PACAP-38 treatment.
  • PACAP-induced differentiation was blocked by the PAC1 receptor antagonist, PACAP6-38.
  • Activation of ERK and p38 MAP kinase was stimulated by PACAP-38.

Takeaway

When a special protein called PACAP-38 is added to certain brain cells, it helps them grow and change into more mature nerve cells.

Methodology

The study involved treating SH-SY5Y cells with PACAP-38 and measuring changes in cell morphology and expression of neuronal markers.

Limitations

The study primarily focused on a single cell line and may not fully represent in vivo conditions.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1111/j.1471-4159.2007.05018.x

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication